# Allogenomic Mismatch Score (AMS) Applied to Haplo-identical Donor/Recipient Pairs in Haematopoietic Stem Cell Transplantation

> **NCT05243498** · — · COMPLETED · sponsor: **Central Hospital, Nancy, France** · enrollment: 80 (actual)

## Conditions studied

- Stem Cell Transplantation
- Haplo-identical

## Interventions

- **OTHER:** Assessment of the Allogenomic Mismatch Score (AMS)
- **OTHER:** Assessment of the optimised Allogenomic Mismatch Score (AMS)

## Key facts

- **NCT ID:** NCT05243498
- **Lead sponsor:** Central Hospital, Nancy, France
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-03-23
- **Primary completion:** 2020-11-06
- **Final completion:** 2020-11-06
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2022-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05243498

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05243498, "Allogenomic Mismatch Score (AMS) Applied to Haplo-identical Donor/Recipient Pairs in Haematopoietic Stem Cell Transplantation". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05243498. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*